文献速递消化道肿瘤与早癌消化内镜

黏膜内结直肠癌的特征、管理与预后再评估及其与T1癌的比较

Reappraisal of the characteristics, management, and prognosis of intramucosal colorectal cancers and their comparison with T1 carcinomas.
PubMed 文献 · Gastrointest Endosc · 2020-06-24

基于人群研究纳入筛查阳性粪隐血后结肠镜诊断的282例黏膜内癌(IMC)和207例T1结直肠癌。IMC多表现为远端结肠≥20 mm带蒂息肉,80.5%内镜切除,无淋巴血管侵犯,预后极佳。与T1癌相比,IMC淋巴结转移、复发、癌相关死亡及内镜切除后出血率均更低。

要点

  • IMC占筛查检出结直肠癌的四分之一,多为远端结肠≥20 mm带蒂息肉。
  • IMC内镜切除占80.5%,外科切除占19.5%,无淋巴血管侵犯征象。
  • 与T1癌相比,IMC淋巴结转移率0% vs 9.5%(P=.041),复发和癌相关死亡均为0%。

核心结论

  • IMC占所有筛查检出结直肠癌的四分之一,无论内镜或外科治疗预后均极佳。
  • IMC在管理与预后方面与T1癌存在显著差异。

研究设计与样本

  • 基于人群研究,纳入筛查项目粪隐血阳性后结肠镜诊断的282例IMC和207例T1结直肠癌。

主要发现

  • IMC主要表现为带蒂息肉(68.4%)、位于远端结肠(69.9%)、大小≥20 mm(60.6%)。
  • IMC内镜切除227例(80.5%),外科切除55例(19.5%);外科患者病变更偏右侧、更多无蒂、更大。
  • 与T1癌相比,IMC无蒂息肉比例更低(31.6% vs 49.8%,P<.0001),首选外科治疗比例更低(19.5% vs 39.1%,P<.0001),最终外科治疗比例更低(19.9% vs 78.7%,P<.0001)。
  • 与T1癌相比,IMC外科患者淋巴结转移率更低(0% vs 9.5%,P=.041),癌复发率更低(0% vs 5.6%),癌相关死亡率更低(0% vs 2.5%),内镜切除后出血率更低(1.8% vs 8.7%,P=.001)。
  • 汇总队列(IMC+T1癌,n=489)多因素分析显示,与一线外科治疗显著相关的因素为息肉特征和行结肠镜检查的消化科医生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The recent description of "invasive" forms of intramucosal carcinoma (IMC) has rekindled interest in studying the characteristics, management, and prognosis of IMCs and comparing them with T1 colorectal cancers (CRCs). METHODS: This population-based study included 282 cases of IMC and 207 cases of T1 CRC diagnosed by colonoscopy after a positive fecal blood test through a screening program. RESULTS: IMC presented mainly in the form of pedunculated polyps (68.4%) located in the distal colon (69.9%) ≥20 mm in size (60.6%). IMCs were resected endoscopically in 227 (80.5%) patients and surgically resected in 55 (19.5%) patients. Surgical patients had more right-sided, more sessile, and larger lesions. There was no sign of lymphovascular invasion. Compared with T1 CRCs, IMCs demonstrated lower rates of sessile polyps (31.6% vs 49.8%, P < .0001), primary and ultimate surgical treatment (19.5% vs 39.1% and 19.9% vs 78.7%, P < .0001, respectively), lymph node metastasis in surgical patients (0% vs 9.5%, P = .041), cancer recurrence and cancer-related mortality (0% vs 5.6% and 0% vs 2.5%, respectively), and bleeding after endoscopic resection (1.8% vs 8.7%, P = .001). By multivariate analysis of the pooled cohort (IMC + T1 CRC, n = 489), the factors significantly associated with first-line surgery were shown to be polyp characteristics and the gastroenterologist who performed the colonoscopy. CONCLUSIONS: IMCs account for a quarter of all screening-detected CRCs. They have an excellent prognosis regardless of whether endoscopic or surgical treatment is performed. IMCs differ significantly from T1 carcinomas in terms of management and prognosis.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bordet M, Bretagne JF, Piette C, et al. Reappraisal of the characteristics, management, and prognosis of intramucosal colorectal cancers and their comparison with T1 carcinomas. Gastrointest Endosc. 2020. PMID: 32590054. doi:10.1016/j.gie.2020.06.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。